Rocuronium reversed by sugammadex for electroconvulsive therapy in a patient with prolonged duration of action of succinylcholine

Anaesthesia and Intensive Care

Volumn 39, Issue 6, 2011, Pages 1153-1154

  Visser, W A ^a   Ermens, A A M ^a   De Boer, H D ^a   Van Os, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; PROPOFOL; ROCURONIUM; SUGAMMADEX; SUXAMETHONIUM; ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR DEPOLARIZING AGENT;

ADULT; ANESTHETIC RECOVERY; BREATHING; CASE REPORT; CHOLINESTERASE BLOOD LEVEL; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; HUMAN; LENGTH OF STAY; LETTER; MALE; MUSCLE RELAXATION; NEUROMUSCULAR TRANSMISSION; PARALYSIS; FEMALE; NOTE;

ANDROSTANOLS; CHOLINESTERASES; ELECTROCONVULSIVE THERAPY; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; NEUROMUSCULAR DEPOLARIZING AGENTS;

EID: 84855410427     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. Eissa S, Lim KS. Rocuronium and sugammadex as a novel management strategy in a patient with plasmacholinesterase deficiency presenting for electroconvulsive therapy. Anaesth Intensive Care 2011; 39:764-765.